# DON in Pediatric Cerebral Malaria

> **NCT05478720** · PHASE1,PHASE2 · RECRUITING · sponsor: **Douglas Postels, MD, MS** · enrollment: 152 (estimated)

## Conditions studied

- Malaria, Cerebral

## Interventions

- **DRUG:** 6-diazo-5-oxo-L-norleucine (DON)
- **DRUG:** Placebo
- **DRUG:** 6-diazo-5-oxo-L-norleucine (DON)

## Key facts

- **NCT ID:** NCT05478720
- **Lead sponsor:** Douglas Postels, MD, MS
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-16
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05478720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05478720, "DON in Pediatric Cerebral Malaria". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05478720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*